Veeva Systems Inc.
Veeva Announces $2 Billion Share Repurchase Program
Summary
On January 5, 2026, Veeva Systems Inc. announced its Board of Directors authorized a share repurchase program for up to $2 billion of Veeva's outstanding shares of Class A common stock. The program allows for repurchases through open market purchases, privately negotiated transactions, or other means in accordance with securities laws. The timing and total amount of repurchases will be determined by management based on various conditions. The program has a term of 2 years and may be canceled or suspended at any time without notice.
Get alerts for VEEV
Be first to know when Veeva Systems Inc. files with the SEC.
Filing Categories
About Veeva Systems Inc.
Veeva Systems Inc. is a cloud-based software solutions provider focusing specifically on the life sciences industry. Its primary function is to develop and deliver specialized software tailored for companies in the pharmaceutical, biotechnology, and medical device sectors. Veeva's product suite includes applications for customer relationship management, content management, collaboration, and data analytics, facilitating enhanced operational efficiency and regulatory compliance. The company’s offerings are designed to optimize the critical aspects of a life sciences company's operations, such as clinical data management, regulatory submissions, and commercial activities. Veeva Systems plays a significant role in the growing digital transformation of the health-related industries, bridging the gap between advanced technological solutions and industry-specific requirements. Founded in 2007 and headquartered in Pleasanton, California, Veeva has established itself as a leader in its niche market, empowering its clients with innovative tools that streamline R&D processes and enhance their go-to-market capabilities.
Official SEC Documents